Published in J Virol on January 01, 1971
An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol (2000) 4.00
Distribution of dengue-2 antigens by electron immunocytochemistry. Infect Immun (1976) 1.29
Cytological localization of Dengue-2 antigens: an immunological study with ultrastructural correlation. Infect Immun (1973) 1.26
NS1 protein secretion during the acute phase of West Nile virus infection. J Virol (2005) 1.22
Antigenic characterization of flavivirus structural proteins separated by isoelectric focusing. J Virol (1977) 1.21
Detection of dengue cell-surface antigens by peroxidase-labeled antibodies and immune cytolysis. Infect Immun (1974) 1.16
Group B arbovirus structural and nonstructural antigens. 3. Serological specificity of solubilized intracellular viral proteins. Infect Immun (1973) 1.08
Group B arbovirus structural and nonstructural antigens. I. Serological identification of Saint Louis encephalitis virus soluble antigens. Infect Immun (1973) 0.95
Effects of cell culture and laboratory conditions on type 2 dengue virus infectivity. J Clin Microbiol (1979) 0.95
Replication of dengue virus type 2 in Aedes albopictus cell culture. J Virol (1973) 0.88
Comparison of the virion polypeptides of group B arboviruses. Infect Immun (1972) 0.87
Virion and soluble antigens of japanese encephalitis virus. Infect Immun (1975) 0.86
Group B arbovirus structural and nonstructural antigens. II. Purification of Saint Louis encephalitis virus intracellular antigens. Infect Immun (1973) 0.85
Reactions of purified hemagglutinating antigens of flaviviruses with 19S and 7S antibodies. Infect Immun (1975) 0.84
Immune response in rabbits to virion and nonvirion antigens of the Flavivirus kunjin. Infect Immun (1977) 0.83
Effect of urea on the hemagglutinating and complement-fixing antigens of type 2 Dengue virus. Infect Immun (1972) 0.77
Enhancement of dengue virus type 2 replication in mouse macrophage cultures by bacterial cell walls, peptidoglycans, and a polymer of peptidoglycan subunits. Infect Immun (1983) 0.76
Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg (1958) 40.44
Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels. Biochem Biophys Res Commun (1967) 32.60
Size and charge isomer separation and estimation of molecular weights of proteins by disc gel electrophoresis. Arch Biochem Biophys (1968) 15.05
Defective viral particles and viral disease processes. Nature (1970) 7.24
Morphogenesis of poliovirus. I. Association of the viral RNA with coat protein. J Mol Biol (1968) 6.58
Precise standardization of reagents for complement fixation. Am J Trop Med Hyg (1963) 6.54
A plaque reduction test for dengue virus neutralizing antibodies. J Immunol (1967) 5.78
Sindbis virus infection of chick and hamster cells: synthesis of virus-specific proteins. Virology (1969) 4.38
Incomplete forms of influenza virus. Adv Virus Res (1954) 3.05
Production and characterization of arbovirus antibody in mouse ascitic fluid. Am J Trop Med Hyg (1967) 2.61
Studies on the nature of dengue viruses. IV. The structural proteins of type 2 dengue virus. Virology (1969) 2.17
Specific cell-surface alteration by enteroviruses as reflected by viral-attachment interference. J Bacteriol (1966) 2.02
The formation of fowl plague virus antigens in infected cells, as studied with fluorescent antibodies. Virology (1957) 2.01
Some properties of the transmissible interfering component of vesicular stomatitis virus preparations. J Gen Microbiol (1959) 1.90
Fractionation of Shope papilloma virus in cesium chloride density gradients. Virology (1962) 1.80
Complete and coreless forms of reovirus (ECHO 10). Ratio of number of virus particles to infective units in the one-step growth cycle. Virology (1961) 1.78
Physical and biological properties of dengue-2 virus and associated antigens. J Virol (1970) 1.75
Studies on the nature of dengue viruses. II. Characterization of viral RNA and effects of inhibitors of RNA synthesis. Virology (1966) 1.74
Anti-dengue immunoglobulins and serum beta 1 c-a globulin levels in dengue shock syndrome. J Immunol (1969) 1.64
STUDIES ON THE STRUCTURE OF A HEMAGGLUTINATING COMPONENT OF A GROUP A ARBO VIRUS (SINDBIS). Virology (1964) 1.62
The physical characteristics of polyoma virus. I. Two types of particle. Virology (1962) 1.60
Studies on the nature of dengue viruses. I. Correlation of particle density, infectivity, and RNA content of type 2 virus. Virology (1965) 1.58
Dengue virions and antigens in brain and serum of infected mice. J Virol (1970) 1.30
Immunochemical characterization of plaque mutants of simian virus 40. J Virol (1969) 1.28
Identification of the A protein as a structural component of bacteriophage R17. J Mol Biol (1968) 1.22
Biological significance of structural adenovirus components. Curr Top Microbiol Immunol (1968) 1.12
COMPLETE AND CORELESS HEMAGGLUTINATING PARTICLES PRODUCED IN ECHO 12 VIRUS-INFECTED CELLS. Virology (1964) 1.11
An insular outbreak of dengue hemorrhagic fever. I. Epidemiologic observations. Am J Trop Med Hyg (1968) 1.08
Relative effect of transcription-level and translation-level control of protein synthesis during early development of the sea urchin. Proc Natl Acad Sci U S A (1970) 0.99
Molecular size and charge relationships of the soluble complement-fixing antigens of dengue viruses. Virology (1970) 0.99
Investigations on the formation and interconversion of Sindbis virus hemagglutinins. Can J Microbiol (1968) 0.94
Group-specific antigen of avian leukosis viruses. Virus specificity and relation to an antigen contained in Rous mammalian tumor cells. Virology (1967) 0.91
Concern Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med (2000) 29.03
Tularemia as a biological weapon: medical and public health management. JAMA (2001) 13.23
Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol (1992) 12.96
Botulinum toxin as a biological weapon: medical and public health management. JAMA (2001) 9.18
Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci U S A (1992) 8.59
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (2000) 8.45
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.96
Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med (1993) 7.29
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.06
Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol (1989) 7.06
A plaque reduction test for dengue virus neutralizing antibodies. J Immunol (1967) 5.78
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (1994) 5.34
Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg (1989) 4.79
Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science (1994) 4.50
Roles for Nkx3.1 in prostate development and cancer. Genes Dev (1999) 4.30
Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am J Trop Med Hyg (1982) 4.04
Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J (1999) 3.79
c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat Med (2001) 3.51
Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. J Exp Med (1993) 3.48
Flaviviridae. Intervirology (1985) 3.06
Transgenic Polyoma middle-T mice model premalignant mammary disease. Cancer Res (2001) 2.97
Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development. Infect Immun (1976) 2.67
Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell (1998) 2.64
The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N Engl J Med (1973) 2.64
Production and characterization of arbovirus antibody in mouse ascitic fluid. Am J Trop Med Hyg (1967) 2.61
Detection of additional antigenic determinants of hepatitis B antigen. J Immunol (1972) 2.57
Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib. Circulation (2001) 2.55
Bunyaviridae. Intervirology (1980) 2.53
Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol Cell Biol (1998) 2.48
Dengue virus identification by the plaque reduction neutralization test. J Immunol (1967) 2.45
Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies. Am J Trop Med Hyg (1982) 2.41
Structural relationships between the RNA of mammary tumor virus and those of other RNA tumor viruses. Virology (1968) 2.39
Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease. Aliment Pharmacol Ther (2004) 2.38
Antigenic characterization of two sindbis envelope glycoproteins separated by isoelectric focusing. Virology (1976) 2.32
Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. Proc Natl Acad Sci U S A (2000) 2.19
v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. Proc Natl Acad Sci U S A (1990) 2.16
Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev (1994) 2.05
Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies. Am J Trop Med Hyg (1985) 2.04
Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol Cell Biol (2001) 2.02
Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease. J Clin Invest (1966) 2.01
Infection of cultured rat hepatoma cells by mouse mammary tumor virus. Cell (1977) 1.98
Togaviridae. Intervirology (1985) 1.96
Rapid identification of dengue virus isolates by using monoclonal antibodies in an indirect immunofluorescence assay. Am J Trop Med Hyg (1983) 1.96
Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J Infect Dis (1971) 1.95
Hemorrhagic fever in Thailand; recent knowledge regarding etiology. Jpn J Med Sci Biol (1967) 1.94
CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol (1998) 1.93
E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis. Mol Cell Biol (2001) 1.91
Protein kinase CK2 in mammary gland tumorigenesis. Oncogene (2001) 1.90
Swine influenza A at Fort Dix, New Jersey (January-February 1976). IV. Summary and speculation. J Infect Dis (1977) 1.88
Interaction of Sindbis virus with liposomal model membranes. J Virol (1975) 1.85
Low-back pain in pregnancy. Spine (Phila Pa 1976) (1987) 1.84
Dengue-virus recovery by direct and delayed plaques in LLC-MK2 cells. Am J Trop Med Hyg (1968) 1.80
Replication of dengue-2 virus in cultured human lymphoblastoid cells and subpopulations of human peripheral leukocytes. J Immunol (1976) 1.79
Diagnosis of gaucher's disease and niemann-pick disease with small samples of venous blood. Science (1967) 1.78
Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2007) 1.75
Physical and biological properties of dengue-2 virus and associated antigens. J Virol (1970) 1.75
Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: interrelationship between the alveolar macrophage and the septal fibroblast. Int J Radiat Oncol Biol Phys (1992) 1.73
Radioimmune precipitation of group A arboviruses. J Immunol (1972) 1.71
Immunoprecipitation analysis of soluble complement-fixing antigens of dengue viruses. J Immunol (1970) 1.69
Change involving a viral membrane glycoprotein during morphogenesis of group B arboviruses. Virology (1972) 1.69
Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect Immun (1982) 1.69
An insular outbreak of dengue hemorrhagic fever. II. Virologic and serologic studies. Am J Trop Med Hyg (1968) 1.68
Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer. Mol Cell Biol (2001) 1.68
Dengue-2 vaccine: preparation from a small-plaque virus clone. Infect Immun (1980) 1.67
Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity. J Virol (1984) 1.66
Anti-dengue immunoglobulins and serum beta 1 c-a globulin levels in dengue shock syndrome. J Immunol (1969) 1.64
The proteins of Japanese encephalitis virus. Virology (1971) 1.63
Isolation and characterization of glucocerebrosidase from human placental tissue. J Biol Chem (1973) 1.62
An analysis of fevers of unknown origin in American soldiers in Vietnam. Ann Intern Med (1967) 1.61
Effects of alterations in cellular iron on biosynthesis of the transferrin receptor in K562 cells. Mol Cell Biol (1985) 1.61
Evidence for two mechanisms of dengue virus infection of adherent human monocytes: trypsin-sensitive virus receptors and trypsin-resistant immune complex receptors. Infect Immun (1981) 1.58
Bunyaviruses and Bunyaviridae. Intervirology (1976) 1.58
Structure of the mouse mammary tumor virus: polypeptides and glycoproteins. J Virol (1974) 1.56
Decreased systolic blood pressure through operant conditioning techniques in patients with essential hypertension. Science (1971) 1.54
Virulence and immunogenicity of a temperature-sensitive dengue-2 virus in lower primates. Infect Immun (1977) 1.51
Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J (1991) 1.50
Antibody response in dengue and dengue hemorrhagic fever. Jpn J Med Sci Biol (1967) 1.47
Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon gamma receptor. Proc Natl Acad Sci U S A (1993) 1.45
Blood pressure morning surge and hostility. Am J Hypertens (1998) 1.45
MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol (1999) 1.44
Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes. Infect Immun (1979) 1.44
Transcription of mouse mammary tumor virus: identification of a candidate mRNA for the long terminal repeat gene product. J Virol (1983) 1.43
Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene (2001) 1.42
Activated neu induces rapid tumor progression. J Biol Chem (1996) 1.39
Experimental infection of chimpanzees with dengue viruses. Am J Trop Med Hyg (1978) 1.39
Swine influenza A at Fort Dix, New Jersey (January-February 1976). I. Case finding and clinical study of cases. J Infect Dis (1977) 1.39
Craniofacial injuries resulting from taxicab accidents in New York City. Ann Plast Surg (1996) 1.38
Swine influenza A at Fort Dix, New Jersey (January-February 1976). III. Extent of spread and duration of the outbreak. J Infect Dis (1977) 1.38